Stay updated with breaking news from Raciu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investment analysts at StockNews.com began coverage on shares of AC Immune (NASDAQ:ACIU – Get Rating) in a research note issued on Thursday. The brokerage set a “sell” rating on the stock. Separately, HC Wainwright reiterated a “buy” rating and set a $16.00 target price on shares of AC Immune in a research note on Wednesday, […] ....
AC Immune SA (NASDAQ:ACIU – Get Rating) – Analysts at SVB Leerink cut their Q3 2023 earnings estimates for AC Immune in a note issued to investors on Thursday, April 20th. SVB Leerink analyst M. Goodman now expects that the company will post earnings of $0.36 per share for the quarter, down from their previous […] ....
HC Wainwright reaffirmed their buy rating on shares of AC Immune (NASDAQ:ACIU – Get Rating) in a report issued on Wednesday, Benzinga reports. They currently have a $16.00 price objective on the stock. Separately, StockNews.com lowered shares of AC Immune from a hold rating to a sell rating in a report on Monday, April 17th. […] ....
StockNews.com lowered shares of AC Immune (NASDAQ:ACIU – Get Rating) from a hold rating to a sell rating in a research report report published on Monday morning. Separately, HC Wainwright restated a buy rating and set a $16.00 price target on shares of AC Immune in a report on Friday, March 17th. AC Immune Price […] ....
AC Immune (NASDAQ:ACIU – Get Rating) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Monday. Separately, HC Wainwright reissued a “buy” rating and set a $16.00 price objective on shares of AC Immune in a research note on Friday, March 17th. […] ....